1. Home
  2. RPHM vs PRT Comparison

RPHM vs PRT Comparison

Compare RPHM & PRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RPHM
  • PRT
  • Stock Information
  • Founded
  • RPHM 2014
  • PRT 2017
  • Country
  • RPHM United States
  • PRT United States
  • Employees
  • RPHM N/A
  • PRT N/A
  • Industry
  • RPHM Biotechnology: Pharmaceutical Preparations
  • PRT Oil & Gas Production
  • Sector
  • RPHM Health Care
  • PRT Energy
  • Exchange
  • RPHM Nasdaq
  • PRT Nasdaq
  • Market Cap
  • RPHM 47.5M
  • PRT 48.8M
  • IPO Year
  • RPHM 2021
  • PRT N/A
  • Fundamental
  • Price
  • RPHM $1.82
  • PRT $3.90
  • Analyst Decision
  • RPHM Hold
  • PRT
  • Analyst Count
  • RPHM 6
  • PRT 0
  • Target Price
  • RPHM $2.26
  • PRT N/A
  • AVG Volume (30 Days)
  • RPHM 345.4K
  • PRT 37.2K
  • Earning Date
  • RPHM 11-11-2024
  • PRT 11-12-2024
  • Dividend Yield
  • RPHM N/A
  • PRT 10.89%
  • EPS Growth
  • RPHM N/A
  • PRT N/A
  • EPS
  • RPHM N/A
  • PRT 0.44
  • Revenue
  • RPHM N/A
  • PRT $6,201,668.00
  • Revenue This Year
  • RPHM N/A
  • PRT N/A
  • Revenue Next Year
  • RPHM N/A
  • PRT N/A
  • P/E Ratio
  • RPHM N/A
  • PRT $8.96
  • Revenue Growth
  • RPHM N/A
  • PRT N/A
  • 52 Week Low
  • RPHM $0.98
  • PRT $3.58
  • 52 Week High
  • RPHM $9.21
  • PRT $6.36
  • Technical
  • Relative Strength Index (RSI)
  • RPHM 69.89
  • PRT 46.08
  • Support Level
  • RPHM $1.61
  • PRT $3.82
  • Resistance Level
  • RPHM $1.75
  • PRT $3.99
  • Average True Range (ATR)
  • RPHM 0.13
  • PRT 0.10
  • MACD
  • RPHM 0.04
  • PRT -0.01
  • Stochastic Oscillator
  • RPHM 87.30
  • PRT 25.00

About RPHM Reneo Pharmaceuticals Inc.

Reneo Pharmaceuticals Inc is a clinical-stage pharmaceutical company. It is focused on the development of therapies for patients with rare genetic mitochondrial diseases, which are often associated with the inability of mitochondria to produce adenosine triphosphate (ATP). The company is developing REN001 to modulate genes critical to metabolism and generation of ATP, which is the primary source of energy for cellular processes.

About PRT PermRock Royalty Trust Trust Units

PermRock Royalty Trust operates as a statutory trust. Its purpose is to own the Net Profits Interest, to distribute to the Trust unitholders cash that it receives in respect of the Net Profits Interest, and to perform certain administrative functions. The Net Profits Interest entitles the trust to receive 80% of the net profits from the sale of oil and natural gas production from the underlying properties of its trustor.

Share on Social Networks: